Research Site — Brick, New Jersey

Research Site is a clinical research site located in Brick, New Jersey, United States 08724.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site has participated in 15 clinical trials with 4 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Asthma, Type 2 Diabetes Mellitus.

Sponsors: Acerta Pharma BV, Bond Avillion 2 Development LP, AstraZeneca.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Brick

Browse all research sites in New Jersey · View every site in Brick

• Ocean University Medical Center
• Ocean Medical Center
• GSK Investigational Site
• New Jersey Hematology Oncology Associates
• Ocean Medical Center at Meridian Health
• Coastal Urology Associates
• New Jersey Center for Cancer Research
• Ocean Allergy & Respiratory Research Center
• Novartis Investigative Site
• For information concerning this clinical site, please contact Nymox at 800-936-9669.
• Seashore Surgical Institute

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 15 clinical trials on record, with 4 currently active. Their work covers Chronic Lymphocytic Leukemia, Asthma, Type 2 Diabetes Mellitus.

Is Research Site accredited by Crixeo Clinical Trials?

Research Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.